Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.07.2021 | Case report

Leflunomide/methotrexate/tocilizumab

Hepatitis-B virus reactivation: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Huang J-X, et al. Successful treatment of tofacitinib in a case with rheumatoid arthritis who experienced hepatitis b virus reactivation induced by tocilizumab and recovered from entecavir rescue therapy. Archives of Rheumatology 36: 458-460, No. 3, Jan 2021. Available from: URL: https://archivesofrheumatology.org/full-text-pdf/1224 Huang J-X, et al. Successful treatment of tofacitinib in a case with rheumatoid arthritis who experienced hepatitis b virus reactivation induced by tocilizumab and recovered from entecavir rescue therapy. Archives of Rheumatology 36: 458-460, No. 3, Jan 2021. Available from: URL: https://​archivesofrheuma​tology.​org/​full-text-pdf/​1224
Metadaten
Titel
Leflunomide/methotrexate/tocilizumab
Hepatitis-B virus reactivation: case report
Publikationsdatum
01.07.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-99929-4

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Antineoplastics

Case report

Multiple drugs